Continuous subcutaneous foscarbidopa/foslevodopa infusion as a therapeutic option in spinocerebellar ataxia type 8 presenting with early-onset parkinsonism
Clinical Parkinsonism & Related Disorders · 2026 · 15 · 100496
DOI: 10.1016/j.prdoa.2026.100496 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Parkinsonism & Related Disorders, 2026. Verfasst von Francesco Onorati und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, MN, USA. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In response to a case report on a patient with spinocerebellar ataxia type 8, presenting with early-onset parkinsonism and treated with deep brain stimulation, we report an analogous case, who responded optimally to continuous subcutaneous foscarbidopa/foslevodopa infusion.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic, Rochester, MN, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
- Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
Zitieren
APA
Onorati, F., Malfer, L., Jackson, L. M., Niu, Z., Ross, O. A., & Savica, R. (2026). Continuous subcutaneous foscarbidopa/foslevodopa infusion as a therapeutic option in spinocerebellar ataxia type 8 presenting with early-onset parkinsonism. Clinical Parkinsonism & Related Disorders, 15, 100496. https://doi.org/10.1016/j.prdoa.2026.100496
Vancouver
Onorati F, Malfer L, Jackson LM, Niu Z, Ross OA, Savica R. Continuous subcutaneous foscarbidopa/foslevodopa infusion as a therapeutic option in spinocerebellar ataxia type 8 presenting with early-onset parkinsonism. Clinical Parkinsonism & Related Disorders. 2026;15:100496. doi:10.1016/j.prdoa.2026.100496
BibTeX
@article{Onorati2026,
author = {Onorati, Francesco and Malfer, Lorenzo and Jackson, Lauren M and Niu, Zhiyv and Ross, Owen A and Savica, Rodolfo},
title = {Continuous subcutaneous foscarbidopa/foslevodopa infusion as a therapeutic option in spinocerebellar ataxia type 8 presenting with early-onset parkinsonism},
journal = {Clinical Parkinsonism & Related Disorders},
year = {2026},
volume = {15},
pages = {100496},
doi = {10.1016/j.prdoa.2026.100496}
}
EUVIMED